BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19451594)

  • 1. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
    Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
    Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.
    Wang W; Rayburn ER; Velu SE; Chen D; Nadkarni DH; Murugesan S; Chen D; Zhang R
    Breast Cancer Res Treat; 2010 Sep; 123(2):321-31. PubMed ID: 19936915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
    Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
    PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.
    Zhang X; Xu H; Zhang X; Voruganti S; Murugesan S; Nadkarni DH; Velu SE; Wang MH; Wang W; Zhang R
    Mar Drugs; 2012 May; 10(5):1138-1155. PubMed ID: 22822362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer.
    Wang F; Ezell SJ; Zhang Y; Wang W; Rayburn ER; Nadkarni DH; Murugesan S; Velu SE; Zhang R
    Invest New Drugs; 2010 Jun; 28(3):234-41. PubMed ID: 19274441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro anti-lung cancer activity of novel 1, 3, 4, 8-tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogs.
    Nadkarni DH; Wang F; Wang W; Rayburn ER; Ezell SJ; Murugesan S; Velu SE; Zhang R
    Med Chem; 2009 May; 5(3):227-36. PubMed ID: 19442212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
    Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
    Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.
    Ezell SJ; Li H; Xu H; Zhang X; Gurpinar E; Zhang X; Rayburn ER; Sommers CI; Yang X; Velu SE; Wang W; Zhang R
    Mar Drugs; 2010 Jul; 8(7):2129-41. PubMed ID: 20714427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
    Tsai SL; Suk FM; Wang CI; Liu DZ; Hou WC; Lin PJ; Hung LF; Liang YC
    Biochem Pharmacol; 2007 Dec; 74(11):1575-86. PubMed ID: 17869226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
    Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
    Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism.
    Jiang Y; Fan L
    J Ethnopharmacol; 2020 Jul; 257():112851. PubMed ID: 32283190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo.
    Carrasco E; Álvarez PJ; Melguizo C; Prados J; Álvarez-Manzaneda E; Chahboun R; Messouri I; Vázquez-Vázquez MI; Aránega A; Rodríguez-Serrano F
    Eur J Med Chem; 2014 May; 79():1-12. PubMed ID: 24704691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-phenylquinolinylchalcone derivatives as potent and selective anticancer agents against breast cancers.
    Tseng CH; Tzeng CC; Hsu CY; Cheng CM; Yang CN; Chen YL
    Eur J Med Chem; 2015 Jun; 97():306-19. PubMed ID: 26005780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
    Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
    Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
    Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer.
    Srirangam A; Mitra R; Wang M; Gorski JC; Badve S; Baldridge L; Hamilton J; Kishimoto H; Hawes J; Li L; Orschell CM; Srour EF; Blum JS; Donner D; Sledge GW; Nakshatri H; Potter DA
    Clin Cancer Res; 2006 Mar; 12(6):1883-96. PubMed ID: 16551874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
    Zhong Z; Dang Y; Yuan X; Guo W; Li Y; Tan W; Cui J; Lu J; Zhang Q; Chen X; Wang Y
    Cell Physiol Biochem; 2012; 30(3):778-90. PubMed ID: 22854281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004):
    Mishra CB; Mongre RK; Prakash A; Jeon R; Supuran CT; Lee MS
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):954-963. PubMed ID: 33947294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.